(Q43687657)

English

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.

scientific article published in August 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Meir J. Stampfer

5

object named as

Stampfer M

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gökhan Hotamışlıgil

3

object named as

Hotamisligil GS

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6

object named as

Rimm EB

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Chu NF

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Spiegelman D

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rifai N

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

157

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

495-503

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Obesity, lipids, and glucose intolerance The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Epidemiology of obesity in relation to health hazards

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Relation of weight change to changes in atherogenic traits: The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Is insulin really a heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

The ob gene and insulin. A relationship leading to clues to the understanding of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Modulation of insulin activities by leptin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Leptin concentrations and insulin sensitivity in normoglycemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Cardiovascular consequences of obesity: role of leptin.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Validity of self-reported waist and hip circumferences in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

The assessment of alcohol consumption by a simple self-administered questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Stability of human plasma leptin concentrations within 36 hours following specimen collection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Maximum Likelihood Estimation of Misspecified Models

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900755-3

7 January 2021

Identifiers

10.1016/S0021-9150(00)00755-3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43687657&oldid=2192685286"